|
|
||||||||
|
FIGURE 1. In vitro binding studies to various tumor cell linesMCF-7, MDA-MB435, HeLaTeton, FRO82-2, FTC133, SW1736, PC-3, DU-145, HNO237, HNO97, HNO210, HNO223, CaCo-2, SW948, and HCT116and to nontumor cell line HPV16-GM and primary endothelial cells HUVEC. Cells were incubated either with 125I-FROP-1 without competitor () or in presence of 104 M unlabeled FROP-1 (+) for 1 h at 37°C. Experiments were performed in triplicate; SDs are shown.
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |